Embattled AMAG braces for October FDA Makena adcom, but it need not worry — analyst
When the FDA approved AMAG Pharmaceuticals’ female libido drug, Vyleesi, months ago sans an advisory committee despite weak data — controversy ensued. But the Massachusetts-based drugmaker …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
